Riverbridge Partners’s Pfizer PFE Stock Holding History

Riverbridge Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,199	Closed	-$205K	–	134
2015 Q1	$205K	Buy	+6,199	New	+$197K	﹤0.01%	130
2014 Q4	–	Sell	-12,669	Closed	-$355K	–	131
2014 Q3	$355K	Hold	12,669	–	–	0.01%	115
2014 Q2	$357K	Sell	12,669 -1,975	-13%	-$56.3K	0.01%	117
2014 Q1	$446K	Hold	14,644	–	–	0.01%	115
2013 Q4	$426K	Hold	14,644	–	–	0.01%	112
2013 Q3	$399K	Hold	14,644	–	–	0.01%	109
2013 Q2	$389K	Buy	+14,644	New	+$405K	0.01%	109

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Riverbridge Partners's PFE Position: Q2 2015 in Review

Riverbridge Partners sold out of Pfizer (PFE) in Q2 2015, closing a stake of 6,199 shares — an estimated $205K sold.

Riverbridge Partners first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $446K in Q1 2014. 1,887 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

Riverbridge Partners reported no remaining Pfizer position as of Q2 2015 after selling out during the quarter.
Riverbridge Partners sold 6,199 Pfizer shares in Q2 2015, an estimated $205K.
Riverbridge Partners first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
Riverbridge Partners's Pfizer position peaked at $446K in Q1 2014.
1,887 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Riverbridge Partners's 13F filing for Q2 2015, filed 20 Jul 2015.